Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Emerg Med ; 53(1): 1-9, 2017 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-28433211

RESUMEN

BACKGROUND: The co-administration of ketamine and propofol (CoKP) is thought to maximize the beneficial profile of each medication, while minimizing the respective adverse effects of each medication. OBJECTIVE: Our objective was to compare adverse events between ketamine monotherapy (KM) and CoKP for procedural sedation and analgesia (PSA) in a pediatric emergency department (ED). METHODS: This was a prospective, randomized, single-blinded, controlled trial of KM vs. CoKP in patients between 3 and 21 years of age. The attending physician administered either ketamine 1 mg/kg i.v. or ketamine 0.5 mg/kg and propofol 0.5 mg/kg i.v. The physician could administer up to three additional doses of ketamine (0.5 mg/kg/dose) or ketamine/propofol (0.25 mg/kg/dose of each). Adverse events (e.g., respiratory events, cardiovascular events, unpleasant emergence reactions) were recorded. Secondary outcomes included efficacy, recovery time, and satisfaction scores. RESULTS: Ninety-six patients were randomized to KM and 87 patients were randomized to CoKP. There was no difference in adverse events or type of adverse event, except nausea was more common in the KM group. Efficacy of PSA was higher in the KM group (99%) compared to the CoKP group (90%). Median recovery time was the same. Satisfaction scores by providers, including nurses, were higher for KM, although parents were equally satisfied with both sedation regimens. CONCLUSIONS: We found no significant differences in adverse events between the KM and CoKP groups. While CoKP is a reasonable choice for pediatric PSA, our study did not demonstrate an advantage of this combination over KM.


Asunto(s)
Sedación Consciente/efectos adversos , Sedación Consciente/métodos , Ketamina/efectos adversos , Propofol/efectos adversos , Adolescente , Anestésicos Disociativos/farmacología , Anestésicos Disociativos/uso terapéutico , Niño , Preescolar , Quimioterapia Combinada/efectos adversos , Quimioterapia Combinada/métodos , Servicio de Urgencia en Hospital/organización & administración , Femenino , Humanos , Ketamina/farmacología , Ketamina/uso terapéutico , Masculino , Pediatría/métodos , Propofol/farmacología , Propofol/uso terapéutico , Estudios Prospectivos , Adulto Joven
2.
Pediatr Emerg Care ; 30(12): 900-1, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25469602

RESUMEN

This is a case report of a 14-year-old boy with autism who presented with photophobia. Physical examination was significant for bilateral corneal ulcers. Differential diagnosis of this chief complaint and the management of the suspected condition are discussed. This case was presented at the Section of Emergency Medicine Meeting at the National Conference and Exhibition of the American Academy of Pediatrics in 2012 and was awarded first place in the PEMpix photograph competition.


Asunto(s)
Úlcera de la Córnea/diagnóstico , Deficiencia de Vitamina A/diagnóstico , Xeroftalmia/diagnóstico , Adolescente , Trastorno Autístico/complicaciones , Distinciones y Premios , Úlcera de la Córnea/terapia , Humanos , Masculino , Trastornos Nutricionales , Fotograbar , Deficiencia de Vitamina A/terapia , Xeroftalmia/terapia
3.
Acad Emerg Med ; 17(2): 187-93, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20370748

RESUMEN

OBJECTIVES: Skin and soft tissue infections (SSTIs) are increasing in incidence, yet there is no consensus regarding management of these infections in the era of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). This study sought to describe current pediatric emergency physician (PEP) management of commonly presenting skin infections. METHODS: This was a cross-sectional survey of subscribers to the American Academy of Pediatrics Section on Emergency Medicine (AAP SoEM) list-serv. Enrollment occurred via the list-serv over a 3-month period. Vignettes of equivocal SSTI, cellulitis, and skin abscess were presented to participants, and knowledge, diagnostic, and therapeutic approaches were assessed. RESULTS: In total, 366 of 606 (60.3%) list-serv members responded. The mean (+/- standard deviation [SD]) duration of practice was 13.6 (+/-7.9) years, and 88.6% practiced in a pediatric emergency department. Most respondents (72.7%) preferred clinical diagnosis alone for equivocal SSTI, as opposed to invasive or imaging modalities. For outpatient cellulitis, PEPs selected clindamycin (30.6%), trimethoprim-sulfa (27.0%), and first-generation cephalosporins (22.7%); methicillin-sensitive S. aureus (MSSA) was routinely covered, but many regimens failed to cover CA-MRSA (32.5%) or group A streptococcus (27.0%). For skin abscesses, spontaneous discharge (67.5%) was rated the most important factor in electing to perform a drainage procedure; fever (19.9%) and patient age (13.1%) were the lowest. PEPs elected to prescribe trimethoprim-sulfamethoxazole (TMP-Sx; 50.0%) or clindamycin (32.7%) after drainage; only 5% selected CA-MRSA-inactive agents. All PEPs suspected CA-MRSA as the etiology of skin abscesses, and many attributed sepsis (22.1%) and invasive pneumonia (20.5%) to CA-MRSA, as opposed to MSSA. However, 23.9% remained unaware of local CA-MRSA prevalence for even common infections. CONCLUSIONS: Practice variation exists among PEPs for management of SSTI. These results can be used to measure changes in SSTI practices as standardized approaches are delineated.


Asunto(s)
Antibacterianos/uso terapéutico , Pautas de la Práctica en Medicina/estadística & datos numéricos , Enfermedades Cutáneas Infecciosas/tratamiento farmacológico , Infecciones de los Tejidos Blandos/tratamiento farmacológico , Adulto , Celulitis (Flemón)/terapia , Clindamicina/uso terapéutico , Infecciones Comunitarias Adquiridas , Estudios Transversales , Servicios Médicos de Urgencia , Encuestas de Atención de la Salud , Humanos , Staphylococcus aureus Resistente a Meticilina
4.
Cancer Res ; 66(8): 4233-9, 2006 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-16618746

RESUMEN

There is evidence that the insulin-like growth factor-I (IGF-I) receptor is required for transformation by a variety of viral and cellular oncogenes in a mouse embryo fibroblast model. To further investigate the IGF-I receptor signaling pathways that are required for the permissive effect of the receptor on transformation by SV40 T antigen, we established three independent fibroblast cell lines each from wild-type and IGF-I receptor null embryos (R-). We transfected the wild-type and R- cell lines with an SV40 T antigen plasmid and selected three clones from each cell line that expressed T antigen. As in previous reports, none of the cloned R- cell lines expressing T antigen were transformed as measured by the ability to form large colonies in soft agar. However, with further passage, all three T antigen-expressing clones from one of the R- cell lines (R(-)3) formed large colonies in soft agar and the transformation of these T antigen-expressing clones was confirmed by tumorigenesis experiments in immunodeficient mice. DNA microarray analysis comparing gene expression between early passage and late passage R(-)3/T antigen clones showed, among other changes, an increase in the expression of ErbB-3 mRNA in the late passage clones. Also, the expression of ErbB-3 protein was dramatically increased in the late passage R(-)3/T antigen clones. We conclude that late passage IGF-I receptor null mouse embryo fibroblasts can be transformed by SV40 T antigen, and that ErbB-3 may play a role in permitting transformation by T antigen.


Asunto(s)
Antígenos Transformadores de Poliomavirus/fisiología , Transformación Celular Neoplásica/metabolismo , Fibroblastos/fisiología , Receptor IGF Tipo 1/deficiencia , Animales , Antígenos Transformadores de Poliomavirus/genética , Procesos de Crecimiento Celular/fisiología , Transformación Celular Neoplásica/genética , Transformación Celular Neoplásica/patología , ADN/biosíntesis , Embrión de Mamíferos , Fibroblastos/metabolismo , Fibroblastos/patología , Quinasa 1 de Adhesión Focal/metabolismo , Proteína Adaptadora GRB2/biosíntesis , Proteína Adaptadora GRB2/genética , Genotipo , Proteínas Sustrato del Receptor de Insulina , Ligandos , Ratones , Ratones Noqueados , Fosfoproteínas/biosíntesis , Fosfoproteínas/genética , Fosforilación , ARN Mensajero/biosíntesis , ARN Mensajero/genética , Receptor ErbB-3/biosíntesis , Receptor ErbB-3/genética , Receptor IGF Tipo 1/genética , Receptor IGF Tipo 1/metabolismo , Transfección
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA